Skip to content
Chronic Lung Diseases
  • HOME
  • NEWS
  • RESOURCES
    • ALPHA-1
    • ASTHMA
    • COPD
    • PULMONARY FIBROSIS
    • SMOKE FREE
    • INHALED MEDICATION
    • BEING ACTIVE
    • CHRONIC COUGH
    • COVID-19
    • PULMONARY HYPERTENSION
    • LUNG CANCER
  • PODCAST
    • SEASON 3: COPD​
    • SEASON 4: COVID-19
    • SEASON 5: AATD
    • SEASON 6: PAH
    • SEASON 7: RESPIRATORY INFECTIONS
    • SEASON 8: COPD BIOLOGICS
    • ALL EPISODES
  • TOOLS
    • Action Plans
      • COPD Action Plan
      • Severe Asthma Action Plan
    • Reports
      • Pulmonary Arterial Hypertension Report – Nov 2025
      • Pneumococcal Vaccination Report – Jan 2025
      • IDEAL Plan – Feb 2025
      • Disease X Preparedness Report – Nov 2024
    • COPD Clinical Tools
  • ABOUT US
  • Sign Up
  • Login
  • FR
Menu Close
News
  • All
  • AATD
  • Being Active
  • Chronic Cough
  • COPD
  • COVID-19
  • Inhaled Medication
  • Pulmonary Fibrosis
  • Smoke Free
  • Pulmonary Hypertension
  • Podcast
  • All
  • AATD
  • Being Active
  • Chronic Cough
  • COPD
  • COVID-19
  • Inhaled Medication
  • Pulmonary Fibrosis
  • Smoke Free
  • Pulmonary Hypertension
  • Podcast
September 3, 2026

Breathless patient, normal X-ray, normal spirometry, no response to treatment. Why that combination points at the right side of the heart, and when to refer. (154 caracteres)

When to Refer a Patient for Pulmonary Hypertension

August 24, 2026

Breathlessness on stairs, fatigue, near-fainting. Why the early signs of pulmonary arterial hypertension are so easy to miss, told from inside the right ventricle.

Early Signs of Pulmonary Arterial Hypertension

August 6, 2026

COPD raises lung cancer risk independently of smoking history. A 2024 meta-analysis found 1.76 times higher risk. The red flags and who to screen.

Lung Cancer and COPD: Understanding the Connection

August 6, 2026

Nearly half of lung cancers in Canada are diagnosed late. The symptoms to watch for, the four steps of diagnosis, and who qualifies for screening.

Lung Cancer Symptoms, Diagnosis and Screening in Canada

August 6, 2026

Non-small cell lung cancer makes up 80-85% of cases in Canada. The two main types, their subtypes, and the biomarkers that decide treatment.

Types of Lung Cancer: NSCLC, SCLC and Subtypes

August 5, 2026

Weight gain, hyperlipidemia, edema and mild CNS changes over two years, with disease control maintained. Identify early, escalate proportionally, communicate clearly.

Lorlatinib in Practice: A Two-Year Case in ALK+ NSCLC

AN INITIATIVE OF

  • Home
  • News
  • Resources
  • Podcast
  • About us
  • Terms of Use
  • Privacy Policy
  • Contact-us
Copyright - Respiplus 2020
Close Menu
  • LOGIN
  • Chronic Lung Diseases: Resources for COPD, Asthma, and more
  • News
  • Resources
  • Le Podcast eXpand
  • About us
  • Contact
  • FR
imunify-bot-check